2024
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
Wells C, Pandey A, Moghadas S, Fitzpatrick M, Singer B, Galvani A. Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States. Annals Of Internal Medicine 2024, 177: 609-617. PMID: 38527289, DOI: 10.7326/m23-2451.Peer-Reviewed Original ResearchSARS-CoV-2 vaccination campaignSARS-CoV-2Centers for Disease Control and PreventionDisease Control and PreventionSARS-CoV-2 vaccinesHealth care costsVaccine-acquired immunityFood and Drug AdministrationU.S. Food and Drug AdministrationControl and PreventionNational Institutes of HealthVaccination campaignInfluenza vaccineInitial doseInstitutes of HealthSARS-CoV-2 variantsBooster doseImmune evasionDrug AdministrationUnited StatesNotsew Orm Sands FoundationDoseHealthPopulation immunityNational Institute
2022
Is life expectancy higher in countries and territories with publicly funded health care? Global analysis of health care access and the social determinants of health
Galvani-Townsend S, Martinez I, Pandey A. Is life expectancy higher in countries and territories with publicly funded health care? Global analysis of health care access and the social determinants of health. Journal Of Global Health 2022, 12: 04091. PMID: 36370409, PMCID: PMC9653205, DOI: 10.7189/jogh.12.04091.Peer-Reviewed Original ResearchConceptsHealth care accessLevel of burdenCare accessSocial determinantsHealth careLife expectancyCountry-level informationMultiple social determinantsLonger life expectancyEconomic stabilityLongevity of lifeMean life expectancyEquitable distributionHealthy agingCareCountriesBurdenDeterminantsExpectancyDescriptive statistical analysisHealthSubstantial impactStatistical analysisQuartile